scarica la rivista in PDF - SIMEUP
scarica la rivista in PDF - SIMEUP
scarica la rivista in PDF - SIMEUP
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Farmaci off-<strong>la</strong>bel <strong>in</strong> Pronto Soccorso Pediatrico<br />
Il difficile equilibrio tra <strong>in</strong>dicazioni, pratica cl<strong>in</strong>ica ed evidenze scientifiche<br />
Bibliografia essenziale<br />
Bibliografia essenziale<br />
1. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric<br />
drug <strong>la</strong>bel<strong>in</strong>g: improv<strong>in</strong>g the safety and efficacy of pediatric<br />
therapies. JAMA 2003; 290: 905-11.<br />
2. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den<br />
Berg LT. Lack of appropriate formu<strong>la</strong>tions of medic<strong>in</strong>es for<br />
children <strong>in</strong> the community. Acta Paediatr 2003; 92: 1486-9.<br />
3. Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M,<br />
Rascher W, Brune K, H<strong>in</strong>z B. The impact of unlicensed and<br />
off-<strong>la</strong>bel drug use on adverse drug reactions <strong>in</strong> paediatric<br />
patients.Drug Saf 2004; 27: 1059-67.<br />
4. Choonara I. Unlicensed and off-<strong>la</strong>bel drug use <strong>in</strong> children:<br />
implications for safety. Expert Op<strong>in</strong> Drug Saf 2004; 3: 81-3.<br />
5. Choonara I, Conroy S. Unlicensed and off-<strong>la</strong>bel drug use <strong>in</strong><br />
children: implications for safety. Drug Saf 2002; 25: 1-5.<br />
Review.<br />
6. Impicciatore P, Choonara I, C<strong>la</strong>rkson A, Provasi D, Pandolf<strong>in</strong>i<br />
C, Bonati M. Incidence of adverse drug reactions <strong>in</strong> paediatric<br />
<strong>in</strong>/out-patients: a systematic review and meta-analysis<br />
of prospective studies. Br J Cl<strong>in</strong> Pharmacol 2001; 52: 77-83.<br />
7. Collier J.Paediatric prescrib<strong>in</strong>g: us<strong>in</strong>g unlicensed drugs and<br />
medic<strong>in</strong>es outside their licensed <strong>in</strong>dications. Br J Cl<strong>in</strong> Pharmacol<br />
1999; 48: 5-8.<br />
8. Pandolf<strong>in</strong>i C, Impicciatore P, Provasi D, Rocchi F, Campi R,<br />
Bonati M; Italian Paediatric Off-<strong>la</strong>bel Col<strong>la</strong>borative Group.<br />
Off-<strong>la</strong>bel use of drugs <strong>in</strong> Italy: a prospective, observational<br />
and multicentre study.Acta Paediatr 2002; 91: 339-47.<br />
9. Pandolf<strong>in</strong>i C, Bonati M. A literature review on off-<strong>la</strong>bel drug<br />
use <strong>in</strong> children.Eur J Pediatr 2005; 164: 552-8.<br />
10. Marchetti F, Bua J, Ventura A, Notarangelo LD, Di Maio S,<br />
Migliore G, Bonati M. The awareness among paediatricians<br />
of off-<strong>la</strong>bel prescrib<strong>in</strong>g <strong>in</strong> children: a survey of Italian hospitals.<br />
Eur J Cl<strong>in</strong> Pharmacol 2007; 63: 81-5.<br />
11. Waller DG.Off-<strong>la</strong>bel and unlicensed prescrib<strong>in</strong>g for children:<br />
have we made any progress? Br J Cl<strong>in</strong> Pharmacol 2007; 64:<br />
1-2.<br />
12. E. Barbi, L. Cantoni. “Prontuario Pediatrico guida al<strong>la</strong> terapia”<br />
sesta edizione, Edifarm.<br />
13. M<strong>in</strong>istero del<strong>la</strong> Salute. Guida all’uso dei farmaci per i bamb<strong>in</strong>i,<br />
Istituto Poligrafico e Zecca dello Stato, 2003.<br />
14. BNF for Children. London: BMJ Publish<strong>in</strong>g Group, 2006.<br />
15. AIFA. Il trattamento farmacologico del vomito <strong>in</strong> età pediatrica.<br />
Bi<strong>la</strong>ncio tra rischi e benefici. BIF 2007: 5; Inserto.<br />
16. L’Erario I, Di Benedetto A, Bua J, Norbedo S, Barbi E, Marchetti<br />
F. Farmaci e utilizzo “Wrong-<strong>la</strong>bel” <strong>in</strong> pediatria. L’esempio<br />
del paracetamolo, del salbutamolo e dell’amoxicill<strong>in</strong>a.<br />
Medico & Bamb<strong>in</strong>o 2007; 26: 580-5.<br />
17. http://www.agenziafarmaco.it./wscs_render_attachment<br />
by_id/111.122704.11691293520533992.pdf, 2008.<br />
18. Mpimbaza A, Ndeezi G, Staedke S, Rosenthal PJ, Byarugaba<br />
J.Comparison of buccal midazo<strong>la</strong>m with rectal<br />
diazepam <strong>in</strong> the treatment of prolonged seizures <strong>in</strong> Ugandan<br />
children: a randomized cl<strong>in</strong>ical trial. Pediatrics 2008;<br />
121: e58-64.<br />
19. Mittal P, Manohar R, Rawat AK. Comparative study of<br />
<strong>in</strong>tranasal midazo<strong>la</strong>m and <strong>in</strong>travenous diazepam sedation<br />
for procedures and seizures. Indian J Pediatr 2006; 73: 975-8.<br />
ANNO 2 - numero 0 | giugno 2008<br />
20. McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse<br />
WP, Phillips B, Mart<strong>la</strong>nd T, Berry K, Collier J, Smith S,<br />
Choonara I. Safety and efficacy of buccal midazo<strong>la</strong>m versus<br />
rectal diazepam for emergency treatment of seizures <strong>in</strong><br />
children: a randomised controlled trial. Lancet 2005; 366:<br />
205-10.<br />
21. Scott RC, Besag FM, Neville BG. Buccal midazo<strong>la</strong>m and rectal<br />
diazepam for treatment of prolonged seizures <strong>in</strong> childhood<br />
and adolescence: a randomised trial. Lancet 1999;<br />
353: 623-6.<br />
22. AIFA. Il foglietto illustrativo: tra strumento comunicativo e<br />
documento rego<strong>la</strong>torio. BIF 2004: 2; 51-6.<br />
23. AIFA. Fogli illustrativi dei Farmaci. BIF 2006: 3; 134-5.<br />
24. http://www.par<strong>la</strong>mento.it/par<strong>la</strong>m/leggi/96648l.htm (legge<br />
648/96).<br />
25. http://www.camera.it/par<strong>la</strong>m/leggi/98094l.htm (legge Di bel<strong>la</strong>).<br />
26. http://gazzette.comune.jesi.an.it/2003/173/2.htm (D.M.<br />
08/05/2003).<br />
Poli<strong>la</strong>t 1 e Poli<strong>la</strong>t 2<br />
Idrolisato sp<strong>in</strong>to di sieroprote<strong>in</strong>e<br />
Formu<strong>la</strong> ipoallergenica<br />
Nutrizionalmente<br />
bi<strong>la</strong>nciata:<br />
presenza di <strong>la</strong>ttosio,<br />
<strong>in</strong>tegrazione con<br />
LCPUFA (solo Poli<strong>la</strong>t 1)<br />
e nucleotidi, per una<br />
crescita adeguata<br />
Riprist<strong>in</strong>a <strong>la</strong> flora<br />
batterica alterata,<br />
grazie all’aggiunta di<br />
oligosaccaridi prebiotici<br />
GOS/FOS<br />
Crescere oggi.<br />
Da 6 a 12 mesi<br />
Da 0 a 6 mesi<br />
<strong>rivista</strong> di EMERGENZA E URGENZA PEDIATRICA | 39